| SUBSCRIBER LOGIN |
|---|
| News Briefs | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||
| Polls |
|---|
| Special Offer |
|---|
|
|
| The Most Misunderstood Medical Treatment In Existence Today |
| Columns - Opinion | ||||||||
| Saturday, 31 May 2003 | ||||||||
|
As a member of NADAAC since November 2000, I feel there needs to be more discussion in our profession concerning Opioid Agonist Treatment. There is a lot going on in this field right now. For example, federal rules have been passed and accreditation will now be required for a program to operate. This is a giant step in recognizing the treatment for what it is, a viable medical option for those seeking treatment for opiate addiction.
Methadone Maintenance Treatment (MMT) is the most
misunderstood medical treatment in existence today. It has survived scrutiny for
35 years and has continuously shown positive results. However, there are still
those who are against the treatment. In their opinion, methadone is no different
from illicit drugs so using it does not qualify as "abstinence." I think we need
to clear up the fact that methadone is not a drug, in the illicit sense, but a
medication that is prescribed by a doctor. There is a big difference between the
two. Since this is true, a person can be abstinent from drugs while still taking
their medication, no matter if it is methadone for addiction, or lithium for
bipolar disorder. It has been proven time and again that most chronic opioid
addicts will need to be maintained on an agonist drug for long periods of time,
many for life. Jay Clarke, is Director of Virginia Alliance of Methadone Advocates, Inc. Visit http://vamethadvocates.org. For more information. He can be reached via e-mail at This e-mail address is being protected from spam bots, you need JavaScript enabled to view it This article is published in Counselor, The Magazine for Addiction Professionals, June 2003, v.4, n.3, pp. 68-69.
Powered by !JoomlaComment 3.25
3.25 Copyright (C) 2007 Alain Georgette / Copyright (C) 2006 Frantisek Hliva. All rights reserved." |
||||||||
| < Prev | Next > |
|---|

















